• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏神经消融策略在晕厥指南中可能发挥什么作用?

What role might cardioneuroablation strategy have in syncope guidelines?

作者信息

Aksu Tolga, Güler Tümer Erdem, Bozyel Serdar, Yalın Kıvanç

机构信息

Department of Cardiology, Kocaeli Derince Training and Research Hospital, Kocaeli, Turkey.

出版信息

Turk Kardiyol Dern Ars. 2019 Jan;47(1):69-79. doi: 10.5543/tkda.2018.10187.

DOI:10.5543/tkda.2018.10187
PMID:30628905
Abstract

Vasovagal syncope (VVS) is the most common type of syncope. Although it is not related to an increase in mortality, recurrent syncope episodes may be disabling and reduce the quality of life. There are no optimal treatment strategies currently available, especially for the cardioinhibitory type of VVS. Cardioneuroablation (CNA) is a relatively novel technique that aims to eliminate vagal efferent output during VVS. The objective of this review was to explore the potential role of CNA strategy in syncope guidelines.

摘要

血管迷走性晕厥(VVS)是最常见的晕厥类型。尽管它与死亡率增加无关,但反复的晕厥发作可能会使人丧失活动能力并降低生活质量。目前尚无最佳治疗策略,尤其是对于心脏抑制型VVS。心脏神经消融术(CNA)是一种相对新颖的技术,旨在消除VVS期间的迷走神经传出冲动。本综述的目的是探讨CNA策略在晕厥指南中的潜在作用。

相似文献

1
What role might cardioneuroablation strategy have in syncope guidelines?心脏神经消融策略在晕厥指南中可能发挥什么作用?
Turk Kardiyol Dern Ars. 2019 Jan;47(1):69-79. doi: 10.5543/tkda.2018.10187.
2
Management strategies for vasovagal syncope.血管迷走性晕厥的管理策略
Pacing Clin Electrophysiol. 2021 Dec;44(12):2100-2108. doi: 10.1111/pace.14402. Epub 2021 Nov 23.
3
Cardioneuroablation for severe neurocardiogenic syncope.心脏神经消融术治疗严重神经心源性晕厥
Rev Port Cardiol. 2023 Oct;42(10):821-829. doi: 10.1016/j.repc.2023.02.012. Epub 2023 Jun 1.
4
Cardioneuroablation for cardioinhibitory vasovagal syncope.心脏神经消融术治疗心脏抑制型血管迷走性晕厥。
J Cardiovasc Electrophysiol. 2021 Jun;32(6):1748-1753. doi: 10.1111/jce.15044. Epub 2021 Apr 27.
5
Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation-A Prospective Randomized Trial.心脏神经消融术治疗反射性晕厥:疗效及对自主心脏调节的影响——一项前瞻性随机试验
JACC Clin Electrophysiol. 2023 Jan;9(1):85-95. doi: 10.1016/j.jacep.2022.08.011. Epub 2022 Aug 28.
6
Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope.心脏减速能力作为心脏神经消融术治疗难治性血管迷走性晕厥患者的指标。
Heart Rhythm. 2022 Apr;19(4):562-569. doi: 10.1016/j.hrthm.2021.12.007. Epub 2021 Dec 9.
7
Cardioneuroablation for the Treatment of Vasovagal Syncope: Current Status and Impact on Quality of Life.心脏神经消融术治疗血管迷走性晕厥:现状和对生活质量的影响。
Curr Cardiol Rep. 2023 Dec;25(12):1839-1849. doi: 10.1007/s11886-023-01997-1. Epub 2023 Nov 20.
8
Cardioneuroablation for Cardioinhibitory Vasovagal Syncope: Rationale, Approaches, and Its Role in Long-Term Management.用于心脏抑制型血管迷走性晕厥的心脏神经消融术:原理、方法及其在长期管理中的作用。
Curr Cardiovasc Risk Rep. 2024 Apr;18(4):55-64. doi: 10.1007/s12170-024-00736-7. Epub 2024 Apr 16.
9
Clinician needs and perceptions about cardioneuroablation for recurrent vasovagal syncope: An international clinician survey.临床医生对复发性血管迷走性晕厥的心神经消融治疗的需求和看法:一项国际临床医生调查。
Heart Rhythm. 2021 Dec;18(12):2160-2166. doi: 10.1016/j.hrthm.2021.08.018. Epub 2021 Aug 19.
10
Cardioinhibitory syncope: from pathophysiology to treatment-should we think on cardioneuroablation?心脏抑制性晕厥:从病理生理学到治疗——我们是否应该考虑心脏神经消融?
J Interv Card Electrophysiol. 2020 Nov;59(2):441-461. doi: 10.1007/s10840-020-00758-2. Epub 2020 May 7.